Structural biology of SARS-CoV-2: open the door for novel therapies
W Yan, Y Zheng, X Zeng, B He, W Cheng - Signal Transduction and …, 2022 - nature.com
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …
COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention
A Sharma, I Ahmad Farouk, SK Lal - Viruses, 2021 - mdpi.com
Three major outbreaks of the coronavirus, a zoonotic virus known to cause respiratory
disease, have been reported since 2002, including SARS-CoV, MERS-CoV and the most …
disease, have been reported since 2002, including SARS-CoV, MERS-CoV and the most …
Recent developments on therapeutic and diagnostic approaches for COVID-19
J Majumder, T Minko - The AAPS journal, 2021 - Springer
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health …
[HTML][HTML] Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Coronavirus disease 2019 is a newly emerging infectious disease currently spreading
across the world. It is caused by a novel coronavirus, severe acute respiratory syndrome …
across the world. It is caused by a novel coronavirus, severe acute respiratory syndrome …
COVID-19 Vaccine: A comprehensive status report
The current COVID-19 pandemic has urged the scientific community internationally to find
answers in terms of therapeutics and vaccines to control SARS-CoV-2. Published …
answers in terms of therapeutics and vaccines to control SARS-CoV-2. Published …
[HTML][HTML] Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
The sudden emergence of severe respiratory disease, caused by a novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently become a public health …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently become a public health …
Nanoparticles in the clinic: An update post COVID‐19 vaccines
AC Anselmo, S Mitragotri - Bioengineering & translational …, 2021 - Wiley Online Library
Nanoparticles are used in the clinic to treat cancer, resolve mineral deficiencies, image
tissues, and facilitate vaccination. As a modular technology, nanoparticles combine …
tissues, and facilitate vaccination. As a modular technology, nanoparticles combine …
Overview of immune response during SARS-CoV-2 infection: lessons from the past
After the 1918 flu pandemic, the world is again facing a similar situation. However, the
advancement in medical science has made it possible to identify that the novel infectious …
advancement in medical science has made it possible to identify that the novel infectious …
Pandemics, transformations and tourism:: Be Careful what you wish for
Disease outbreaks and pandemics have long played a role in societal and economic
change. However, the nature of such change is selective, meaning that it is sometimes …
change. However, the nature of such change is selective, meaning that it is sometimes …
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response
I Astuti - Diabetes & Metabolic Syndrome: Clinical Research & …, 2020 - Elsevier
Background and aim As a result of its rapid spread in various countries around the world, on
March 11, 2020, WHO issued an announcement of the change in coronavirus disease 2019 …
March 11, 2020, WHO issued an announcement of the change in coronavirus disease 2019 …